We are live on ! Find out more
CIC

Cornercap Investment Counsel Portfolio holdings

AUM $203M
1-Year Est. Return 17.67%
This Fund
S&P 500
This Quarter Est. Return
-2.06%
1 Year Est. Return
+17.67%
3 Year Est. Return
+55.44%
5 Year Est. Return
+79.88%
10 Year Est. Return
+193.02%
AUM
$614M
AUM Growth
-$35.7M
Cap. Flow
-$16.7M
Cap. Flow %
-2.73%
Top 10 Hldgs %
8.77%
Holding
722
New
115
Increased
83
Reduced
345
Closed
120

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$3.16M
2
AMD icon
Advanced Micro Devices
AMD
+$2.25M
3
VEEV icon
Veeva Systems
VEEV
+$2.23M
4
FANG icon
Diamondback Energy
FANG
+$2.21M
5
PCG icon
PG&E
PCG
+$2.18M

Top Sells

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$2.94M
2
GD icon
General Dynamics
GD
+$2.93M
3
PSX icon
Phillips 66
PSX
+$2.76M
4
ALGN icon
Align Technology
ALGN
+$2.65M
5
LHX icon
L3Harris
LHX
+$2.56M

Sector Composition

Rank Sector Weight
1 Financials 18.75%
2 Technology 17.73%
3 Healthcare 12.62%
4 Industrials 11.81%
5 Consumer Discretionary 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VERV
576
DELISTED
Verve Therapeutics
VERV
$73K 0.01%
14,956
+1,778
+13% +$11.2K
MGNX icon
577
MacroGenics
MGNX
$257M
$68.1K 0.01%
16,025
-192
-1% -$1.87K
ALXO icon
578
ALX Oncology
ALXO
$290M
$62.1K 0.01%
10,292
-148
-1% -$1.82K
CRBU icon
579
Caribou Biosciences
CRBU
$164M
$57.9K 0.01%
35,305
-449
-1% -$1.44K
BTE icon
580
Baytex Energy
BTE
$2.92B
$52.2K 0.01%
15,068
-4,209
-22% -$15.1K
ZNTL icon
581
Zentalis Pharmaceuticals
ZNTL
$302M
$51.5K 0.01%
12,582
KRON
582
DELISTED
Kronos Bio
KRON
$49.9K 0.01%
40,208
-1,143
-3% -$1.16K
ACET icon
583
Adicet Bio
ACET
$74.7M
$46.8K 0.01%
2,417
+29
+1% +$777
ALDX icon
584
Aldeyra Therapeutics
ALDX
$93.5M
-61,601
Closed -$201K
ALE
585
DELISTED
Allete
ALE
-17,229
Closed -$1.03M
ALGN icon
586
Align Technology
ALGN
$12.3B
-8,092
Closed -$2.65M
ATMU icon
587
Atmus Filtration Technologies
ATMU
$4.18B
-45,257
Closed -$1.46M
AWK icon
588
American Water Works
AWK
$26.9B
-8,895
Closed -$1.09M
BBW icon
589
Build-A-Bear
BBW
$462M
-22,909
Closed -$684K
BIIB icon
590
Biogen
BIIB
$30.7B
-3,599
Closed -$776K
BLBD icon
591
Blue Bird Corp
BLBD
$2.18B
-26,771
Closed -$1.03M
BRC icon
592
Brady Corp
BRC
$4.57B
-18,250
Closed -$1.08M
CABO icon
593
Cable One
CABO
$212M
-1,846
Closed -$781K
CLDT
594
Chatham Lodging
CLDT
$586M
-71,360
Closed -$721K
CLW icon
595
Clearwater Paper
CLW
$376M
-30,277
Closed -$1.32M
CLX icon
596
Clorox
CLX
$12.7B
-8,805
Closed -$1.35M
CME icon
597
CME Group
CME
$94.8B
-4,184
Closed -$901K
CNP icon
598
CenterPoint Energy
CNP
$26.8B
-40,499
Closed -$1.15M
COCO icon
599
Vita Coco
COCO
$3.6B
-25,421
Closed -$621K
CPRX
600
DELISTED
Catalyst Pharmaceutical
CPRX
-12,216
Closed -$195K

Similar funds

Cornercap Investment Counsel's Q2 2024 Portfolio in Review

As of Q2 2024, Cornercap Investment Counsel held 722 positions worth $614M, down 5.5% from $649M the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.

Cornercap Investment Counsel's Q2 2024 filing shows 115 new, 83 increased, 345 reduced and 120 closed positions. Its largest new stake was Comcast: 80,638 shares worth $3.16M. The largest sale was Palo Alto Networks, an estimated $2.94M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.

  • Cornercap Investment Counsel's largest Q2 2024 buy was Comcast: 80,638 shares worth $3.16M.
  • Cornercap Investment Counsel added most to Advanced Micro Devices in Q2 2024, an estimated $2.25M increase.
  • Cornercap Investment Counsel's biggest Q2 2024 reduction was Palo Alto Networks, cutting an estimated $2.94M.
  • Cornercap Investment Counsel fully exited General Dynamics in Q2 2024, selling an estimated $2.93M.
  • Cornercap Investment Counsel's ten largest holdings make up 8.8% of its $614M portfolio in Q2 2024.
  • Cornercap Investment Counsel opened 115 new positions and closed 120 in Q2 2024.
  • Cornercap Investment Counsel's portfolio value fell 5.5% quarter-over-quarter to $614M.

Based on Cornercap Investment Counsel's 13F filing for Q2 2024, filed 8 Aug 2024.